Nanobiotix appoints CordenPharma as CMO for potential nanoparticle-based cancer treatment
The late clinical-stage nanomedicine company Nanobiotix has selected CordenPharma as its contract manufacturing partner.
The late clinical-stage nanomedicine company Nanobiotix has selected CordenPharma as its contract manufacturing partner.
The FDA has defended the speed at which it finalises draft guidance on drugs in response to criticism from Republican senators.
European CMO PharmaCell B.V. has finalized an agreement with ImmunoCellular Therapeutics to support its pivotal phase III clinical trial in Europe with ICT-107, a dendritic cell-based vaccine in development for glioblastoma multiforme, a form of brain...
Sigma-Aldrich has signed an exclusive agreement with Roche to distribute its biochemical reagents product portfolio via Sigma’s eCommerce and supply chain capabilities. The companies did not disclose any of the financial details of the deal.
3D printers have been used to create tailor-made drug delivery tools, including bioactive radiology devices.
The pharma industry reached a high water mark in 2014 with a record number of new molecular entities approved by the US Food and Drug Administration, especially orphan drugs.